The application of cognitive-behavioral therapy for psychosis in clinical and research settings.

The application of cognitive-behavioral therapy for psychosis in clinical and research settings. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The application of cognitive-behavioral therapy for psychosis in clinical and research settings. Abstract Text:

Rebecca Rollinson,Catherine Haig,Richard Warner,Philippa Garety,Elizabeth Kuipers,Daniel Freeman,Paul Bebbington,Graham Dunn,David Fowler,Rebecca Rollinson,Catherine Haig,Richard Warner,Philippa Garety,Elizabeth Kuipers,Daniel Freeman,Paul Bebbington,Graham Dunn,David Fowler,

OBJECTIVE: This study compared the practice of cognitive-behavioral therapy (CBT) for psychosis across research and routine clinical settings. METHODS: An observer-rated adherence measure was used to compare the content of 40 therapy sessions of clients with positive psychotic symptoms. Twenty therapist-client dyads came from a research setting in the United Kingdom and 20 from three clinical settings, two in the United Kingdom and one in the United States. In the research setting CBT was provided by research clinical psychologists and trained local therapists. In the clinical settings CBT was part of a case management service by trained therapists. RESULTS: Therapist adherence to CBT for psychosis did not differ between the research and clinical settings. However, clinicians in the research settings scored significantly higher on items for schema work (z=-1.98, p<.05), relapse prevention interventions (z=-2.08, p<.05), and formulating a model of relapse (z=-2.61, p<.01). CONCLUSIONS: CBT for psychosis conducted in clinical settings was more strongly characterized by assessment of symptoms and work on coping strategies and less so by relapse prevention and schema-level work. Relapse prevention interventions and schema work could be considered more challenging for therapists to undertake. The findings suggest that therapists working in routine clinical settings are able to establish good therapeutic relationships with people with psychosis and to work on assessing and coping with their psychotic symptoms. However, some therapeutic approaches may be more challenging in this context.

The application of cognitive-behavioral therapy for psychosis in clinical and research settings. Publishing Authors By Initials

R Rollinson,C Haig,R Warner,P Garety,E Kuipers,D Freeman,P Bebbington,G Dunn,D Fowler,R Rollinson,C Haig,R Warner,P Garety,E Kuipers,D Freeman,P Bebbington,G Dunn,D Fowler,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The application of cognitive-behavioral therapy for psychosis in clinical and research settings. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Psychiatric services (Washington, D.C.)

VOLUME: 58

Page Numbers: 1297-302

Journal Abbreviation:

ISSN: 1075-2730

DAY: 4

MONTH: Oct

YEAR: 2007

The application of cognitive-behavioral therapy for psychosis in clinical and research settings. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9502838

The application of cognitive-behavioral therapy for psychosis in clinical and research settings. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The application of cognitive-behavioral therapy for psychosis in clinical and research settings. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The application of cognitive-behavioral therapy for psychosis in clinical and research settings.

AFFILIATION: Psychological Therapies and Primary Care, Norfolk and Waveney Mental Health Partnership NHS Trust, Community Resource Centre, Northgate Hospital, Great Yarmouth NR30 1BU, United Kingdom. rebecca.rollinson@nwmhp.nhs.uk

Country: United States

AGENCY: United Kingdom Wellcome T

GRANT: 062452

ACRONYM:

MEDLINETA: Psychiatr Serv

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The application of cognitive-behavioral therapy for psychosis in clinical and research settings Related Publications

• A bold new beginning for midwifery in Afghanistan.
• A descriptive analysis of Emergency Medical Service Systems participating in the Resuscitation Outcomes Consortium (ROC) network.
• A fatality from sevoflurane abuse.
• A molecular characterization of spontaneous frameshift mutagenesis within the trpA gene of Escherichia coli.
• Artificial breeding of non-domestic animals Watson, P.F. (ed.): Symposium 43, of the Zoological Society of London. London & N.Y., Academic Press. 1978. Price: 16 pounds (British).
• Chronic ingestion of (3R,3'R,6'R)-lutein and (3R,3'R)-zeaxanthin in the female rhesus macaque.
• Contentious issue of funding and the pharmaceutical industry--should service user groups take the big pharma shilling, and and what are the costs if they do?
• Distribution of phencyclidine into vitreous humor.
• Double-bridged Flap Procedure for Nonmarginal, Full-thickness, Upper Eyelid Reconstruction.
• Editorial comment on: extracorporeal magnetic stimulation is of limited clinical benefit to women with idiopathic detrusor overactivity: a randomized sham controlled trial.
• Hypoxia inducible factor-1 modulates hemin-induced IL-8 secretion in microvascular endothelium.
• Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial.
• Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake.
• Measuring forelimb force control and movement in Fischer 344/Brown Norway rats: effects of age and lorazepam.
• Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial of a Polyclonal Anti-Staphylococcus aureus Capsular Polysaccharide Immune Globulin in Treatment of Staphylococcus aureus Bacteremia.
• Predicted light scattering from particles observed in human age-related nuclear cataracts using mie scattering theory.
• Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia.
• Role of macromolecular assembly of enamel matrix proteins in enamel formation.
• Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alpha7 nicotinic cholinergic agonist drug.
• Synthesis and positron emission tomography studies of carbon-11-labeled imatinib (Gleevec).
• The application of cognitive-behavioral therapy for psychosis in clinical and research settings.
• The association between traumatic experience, paranoia and hallucinations: a test of the predictions of psychological models.
• The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action.
• The influence of crank length and cadence on mechanical efficiency in hand cycling.
• The pharmacology of the cannabinoid system--a question of efficacy and selectivity.
• Tmod3 regulates polarized epithelial cell morphology.
• Tropomodulin 3 binds to actin monomers.
• Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.
• Visual influences on perception of speech and nonspeech vocal-tract events.
• Who's stigmatising whom?